The proportion of cases of hepatocellular carcinoma (HCC) attributable to fatty liver disease is set to rise in the…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
BILIARY ATRESIA
NewsStudy finds a new player behind liver scarring in biliary atresia
A new study has uncovered a key mechanism behind the liver scarring seen in biliary atresia (BA), a rare…
The first participant has been enrolled in ECLIPSE 3, a Phase 2b clinical trial testing Vir Biotechnology’s combination treatment…
CHOLESTASIS
NewsStudy links low vitamin D to severe liver damage in cholestasis
Low levels of vitamin D by-products, or metabolites, in the blood are indicative of more severe liver damage in…
FATTY LIVER DISEASE
NewsStudy testing fatty liver disease MASH therapy almost fully enrolled
Enrollment is nearly complete in a Phase 2b clinical trial that’s testing Corcept Therapeutics‘ experimental oral therapy miricorilant in…
World Hepatitis Day arrives Monday and advocates are gearing up to break down barriers that stand in the way of…
HEPATITIS
NewsHepatitis E virus can also infect kidney cells: Study
The hepatitis E virus (HEV) has long been known to infect liver cells, but researchers have now shown it…
FATTY LIVER DISEASE
NewsEMA committee supports Rezdiffra’s OK for fatty liver disease MASH
A committee of the European Medicines Agency (EMA) has granted a positive opinion to Rezdiffra (resmetirom) to treat some people…
HEPATITIS
NewsClinical testing begins for vaccine to treat hepatitis B
Astrivax Therapeutics has begun clinical testing of AVX70371, an experimental vaccine designed to treat hepatitis B. “Starting clinical development…
FATTY LIVER DISEASE
NewsScientists call for more efforts to diagnose liver disease MASH
An international team of scientists called for more efforts to diagnose metabolic dysfunction-associated steatohepatitis (MASH), a severe form of…